The antitumorigenic trifecta

Blood

Volumn 114, Issue 9, 2009, Pages 1727-1728

  Mowery, Yvonne M ^a   Pizzo, Salvatore V ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; CELL SURFACE RECEPTOR; MALATE DEHYDROGENASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; DRUG HALF LIFE; ENZYME INHIBITION; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NEOPLASM; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 70449556825     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-06-226233     Document Type: Note

References (9)

1. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79(2): 315-328. (Pubitemid 24324921)
2. Lee T-Y, Muschal S, Pravda EA, Folkman J, Abdollahi A, Javaherian K. Angiostatin regulates the expression of antiangiogenic and proapoptotic pathways via targeted inhibition of mitochondrial proteins. Blood. 2009;114(9):1987- 1998.
3. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 1996;2(6):689-692. (Pubitemid 26191958)
4. Moser TL, Stack MS, Asplin I, et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad SciU S A. 1999;96(6):2811-2816. (Pubitemid 29148800)
5. Moser TL, Kenan DJ, Ashley TA, et al. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci U S A. 2001;98(12):6656-6661.
6. Chen YH,Wu HL, Li C, et al. Anti-angiogenesis mediated by angiostatin K1-3, K1-4 and K1-4.5. Involvement of p53, FasL,AKTandmRNAderegulation. Thromb Haemost. 2006;95(4):668-677.
7. Chi SL, Pizzo SV. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase. Cancer Res. 2006; 66(2):875-882.
8. Perri SR, Annabi B, Galipeau J. Angiostatin inhibits monocyte/macrophage migration via disruption of actin cytoskeleton. FASEB J. 2007;21(14):3928-3936. (Pubitemid 350232350)
9. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1-9. (Pubitemid 351324128)